" class="no-js "lang="en-US"> Pascal Prigent - Medtech Alert
Thursday, March 30, 2023
Pascal Prigent

Pascal Prigent

About Pascal Prigent

20+ years of marketing, sales and general management experience in Europe, the US and Latin America. Most significant experience in neurosciences, diabetes, oncology, respiratory and vaccines.
Product launches, market access, business turnaround and growth strategy.

Related Story

GENFIT Acquires Swiss Biotech Versantis for Over CHF105 Million

September 20 2022

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of […]

Genoscience Pharma Licenses GNS561, its PPT-1 Inhibitor, to GENFIT in Cholangiocarcinoma Indication in US/Canada and Europe

December 17 2021

Genoscience Pharma, a clinical stage biotechnology company developing unique lysosomotropic drug candidates for the treatment of […]